We are live on ! Find out more
OSTX

OS Therapies Inc

6 hedge funds and large institutions have $599K invested in OS Therapies Inc in 2025 Q1 according to their latest regulatory filings, with 2 funds opening new positions, 2 increasing their positions, 1 reducing their positions, and 1 closing their positions.

New
Increased
Maintained
Reduced
Closed

100% more first-time investments, than exits

New positions opened: 2 | Existing positions closed: 1

100% more repeat investments, than reductions

Existing positions increased: 2 | Existing positions reduced: 1

20% more funds holding

Funds holding: 56 (+1)

1.11% more ownership

Funds ownership: 0.68%1.79% (+1.1%)

3% less capital invested

Capital invested by funds: $621K → $599K (-$21.3K)

Holders
6
Holders Change
+1
Holders Change %
+20%
% of All Funds
0.08%
Holding in Top 10
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
2
Increased
2
Reduced
1
Closed
1
Calls
Puts
Net Calls
Net Calls Change

OSTX Hedge Fund Activity: Q1 2025 in Review

6 of the 7,473 institutional investors tracked by Wall St. Rank reported a position in OS Therapies Inc (OSTX) for Q1 2025, worth a combined $599K — down 3.4% from $621K a quarter earlier.

Buyers outnumbered sellers: 2 funds opened new OSTX positions and 1 closed out — a net gain of 1 holder — while 2 added to existing stakes and 1 trimmed.

The largest buyer was CM Management, adding an estimated $446K. The largest seller was Millennium Management, exiting entirely with an estimated $128K sold.

  • 6 institutional investors held OS Therapies Inc (OSTX) as of Q1 2025, up from 5 in Q4 2024.
  • Funds reported $599K of OS Therapies Inc stock for Q1 2025, down 3.4% quarter-over-quarter.
  • 2 funds opened new OS Therapies Inc positions in Q1 2025 and 1 closed out, a net change of +1 holder.
  • The largest OS Therapies Inc buyer in Q1 2025 was CM Management, an estimated $446K added.
  • The largest OS Therapies Inc seller in Q1 2025 was Millennium Management, an estimated $128K sold.

Based on aggregated 13F filings for Q1 2025.